Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
80 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global sleep apnea devices market is expected to witness substantial growth owing to high prevalence of Obstructive Sleep Apnea (OSA) patients. Downsides of urban lifestyle such as long working hours, obesity, diabetes, and anxiety have resulted in increased sleep disorders, consequently driving sleep apnea devices demand. Leading market players have invested heavily in the development of compact therapeutic devices, which is expected to favorably impact sleep apnea devices market growth. Lack of patient compliance and discomfort caused by the devices may pose a challenge to industry participants. Further key findings from the study suggest: Diagnostic sleep apnea devices accounted for over 50% of the overall market in 2013; however, they are expected to lose market share to therapeutic devices by 2020, which are projected to overtake the former. PSG devices contributed over 25% to the overall diagnostic sleep apnea devices market revenue in 2013. PAP devices accounted for over 20% of the overall therapeutic sleep apnea devices market revenue in 2013. Oral appliances are expected to gain therapeutic devices market share over the forecast period. North America dominated the market in 2013, accounting for approximately 35% of the overall revenue. This can be attributed to increased sleep apnea awareness, increased obesity among the population, sophisticated healthcare infrastructure and high insurance coverage in the region. The Asia Pacific sleep apnea devices market is relatively untapped and has high growth potential over the forecast period, with the level of awareness projected to increase among patients and the medical fraternity. The sleep apnea devices market is highly consolidated, with ResMed and Philips Respironics accounting for a considerable percentage of the overall revenue. Other manufacturers include Weinmann Medical Devices, Natus Medical, Fisher & Paykel Healthcare, DeVilbiss Healthcare, and CareFusion. For the purpose of this study, Grand View Research has segmented the global sleep apnea devices market on the basis of product and region: Sleep Apnea Devices Product Outlook (Revenue, USD Million, 2012 - 2020) Diagnostic Devices Actigraphy Systems Polysomnography (PSG) Devices Respiratory Polygraph Single Channel Screening Devices (Pulse Oximeters) Therapeutic Devices Adaptive Servo Ventilation (ASV) Systems Airway Clearance Systems Positive Airway Pressure (PAP) Devices Oral Appliances Oxygen Devices Others Sleep Apnea Devices Regional Outlook (Revenue, USD Million, 2012 - 2020) North America Europe Asia Pacific RoW
Table of Contents
Chapter 1. Executive Summary 1.1. Sleep Apnea Devices - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Sleep Apnea Devices Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Sleep Apnea Devices Value Chain Analysis 2.4. Sleep Apnea Devices Market Dynamics 2.4.1. Market Driver Analysis 2.4.2. Market Restraint Analysis 2.5. Key Opportunities Prioritized 2.6. Industry Analysis - Porter's 2.7. Sleep Apnea Devices - Key Company Analysis, 2013 2.8. Sleep Apnea Devices Market PESTEL Analysis, 2013 Chapter 3. Sleep Apnea Devices Product Outlook 3.1. Diagnostic Devices 3.1.1. Actigraphy Systems 3.1.1.1. Global demand, by region, (Revenue), 2012 - 2020 3.1.2. Polysomnography (PSG) Devices 3.1.2.1. Global demand, by region, (Revenue), 2012 - 2020 3.1.3. Respiratory Polygraph 3.1.3.1. Global demand, by region, (Revenue), 2012 - 2020 3.1.4. Single Channel Screening Devices (Pulse Oximeters) 3.1.4.1. Global demand, by region, (Revenue), 2012 - 2020 3.2. Therapeutic Devices 3.2.1. Adaptive Servo Ventilation (ASV) Systems 3.2.1.1. Global demand, by region, (Revenue), 2012 - 2020 3.2.2. Airway Clearance Systems 3.2.2.1. Global demand, by region, (Revenue), 2012 - 2020 3.2.3. Positive Airway Pressure (PAP) Devices 3.2.3.1. Global demand, by region, (Revenue), 2012 - 2020 3.2.4. Oral Appliances 3.2.4.1. Global demand, by region, (Revenue), 2012 - 2020 3.2.5. Oxygen Devices 3.2.5.1. Global demand, by region, (Revenue), 2012 - 2020 3.2.6. Others 3.2.6.1. Global demand, by region, (Revenue), 2012 - 2020 Chapter 4. Sleep Apnea Devices Regional Outlook 4.1. North America 4.1.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.1.2. U.S. 4.1.2.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.1.3. Mexico 4.1.3.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.2. Europe 4.2.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.2.2. Germany 4.2.2.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.2.3. UK 4.2.3.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.3. Asia Pacific 4.3.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.3.2. China 4.3.2.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.3.3. India 4.3.3.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.3.4. Japan 4.3.4.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.4. RoW 4.4.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 4.4.2. Brazil 4.4.2.1. Sleep apnea devices market by product, (Revenue), 2012 - 2020 Chapter 5 Sleep Apnea Devices Competitive landscape 5.1 Apnex Medical Inc 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 BMC Medical Co., Ltd. 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 Braebon Medical Corporation 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 Cadwell Laboratories Inc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 CareFusion Corp. 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 Compumedics Limited 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Curative Medical Inc. 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives 5.8 Fisher & Paykel Healthcare 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 GE Healthcare 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 Global Medical Holdings, LLC 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 ImThera Medical, Inc. 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives 5.12 Invacare Corporation 5.12.1 Company Overview 5.12.2 Financial Performance 5.12.3 Product Benchmarking 5.12.4 Strategic Initiatives 5.13 Itamar Medical Ltd. 5.13.1 Company Overview 5.13.2 Financial Performance 5.13.3 Product Benchmarking 5.13.4 Strategic Initiatives 5.14 Natus Medical Inc. 5.14.1 Company Overview 5.14.2 Financial Performance 5.14.3 Product Benchmarking 5.14.4 Strategic Initiatives 5.15 Nihon Kohden 5.15.1 Company Overview 5.15.2 Financial Performance 5.15.3 Product Benchmarking 5.15.4 Strategic Initiatives 5.16 Philips Healthcare 5.16.1 Company Overview 5.16.2 Financial Performance 5.16.3 Product Benchmarking 5.16.4 Strategic Initiatives 5.17 ResMed, Inc. 5.17.1 Company Overview 5.17.2 Financial Performance 5.17.3 Product Benchmarking 5.17.4 Strategic Initiatives 5.18 Somnetics International, Inc. 5.18.1 Company Overview 5.18.2 Financial Performance 5.18.3 Product Benchmarking 5.18.4 Strategic Initiatives 5.19 SOMNOmedics GmbH Medizintechnik 5.19.1 Company Overview 5.19.2 Financial Performance 5.19.3 Product Benchmarking 5.19.4 Strategic Initiatives 5.20 Teleflex, Inc. 5.20.1 Company Overview 5.20.2 Financial Performance 5.20.3 Product Benchmarking 5.20.4 Strategic Initiatives 5.21 Weinmann Medical Devices GmbH & co. KG 5.21.1 Company Overview 5.21.2 Financial Performance 5.21.3 Product Benchmarking 5.21.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources List of Tables 1. Sleep Apnea Devices - Industry Summary & Critical Success Factors (CSFs) 2. Global sleep apnea devices market (Revenue), 2012 - 2020 3. Global sleep apnea devices market by region (Revenue), 2012 - 2020 4. Global sleep apnea devices market by product (Revenue), 2012 - 2020 5. Global actigraphy systems demand, (Revenue), 2012 - 2020 6. Global actigraphy systems demand, by region, (Revenue), 2012 - 2020 7. Global PSG devices demand, (Revenue), 2012 - 2020 8. Global PSG devices demand, by region, (Revenue), 2012 - 2020 9. Global respiratory polygraph demand, (Revenue), 2012 - 2020 10. Global respiratory polygraph demand, by region, (Revenue), 2012 - 2020 11. Global pulse oximeters demand, (Revenue), 2012 - 2020 12. Global pulse oximeters demand, by region, (Revenue), 2012 - 2020 13. Global ASV systems demand, (Revenue), 2012 - 2020 14. Global ASV systems demand, by region, (Revenue), 2012 - 2020 15. Global airway clearance systems demand, (Revenue), 2012 - 2020 16. Global airway clearance systems demand, by region, (Revenue), 2012 - 2020 17. Global PAP devices demand, (Revenue), 2012 - 2020 18. Global PAP devices demand, by region, (Revenue), 2012 - 2020 19. Global oral appliances demand, (Revenue), 2012 - 2020 20. Global oral appliances demand, by region, (Revenue), 2012 - 2020 21. Global oxygen devices demand, (Revenue), 2012 - 2020 22. Global oxygen devices demand, by region, (Revenue), 2012 - 2020 23. Global other devices demand, (Revenue), 2012 - 2020 24. Global other devices demand, by region, (Revenue), 2012 - 2020 25. North America sleep apnea devices market by product (Revenue), 2012 - 2020 26. Europe sleep apnea devices market by product (Revenue), 2012 - 2020 27. Asia Pacific sleep apnea devices market by product (Revenue), 2012 - 2020 28. RoW sleep apnea devices market by product (Revenue), 2012 - 2020 List of Figures 1. Sleep Apnea Devices Market Segmentation 2. Global sleep apnea devices market (Revenue), 2012 - 2020 3. Sleep apnea devices value chain analysis 4. Sleep apnea devices market dynamics 5. Sleep apnea devices - Company market share analysis, 2013 6. Key Opportunities Prioritized 7. Industry Analysis - Porter's 8. Sleep Apnea Devices PESTEL Analysis, 2013 9. Sleep Apnea Devices market share by product, 2013 & 2020 10. Global actigraphy systems demand, (Revenue), 2012 - 2020 11. Global PSG devices demand, (Revenue), 2012 - 2020 12. Global respiratory polygraph demand, (Revenue), 2012 - 2020 13. Global pulse oximeters demand, (Revenue), 2012 - 2020 14. Global ASV systems demand, (Revenue), 2012 - 2020 15. Global airway clearance systems demand, (Revenue), 2012 - 2020 16. Global PAP devices demand, (Revenue), 2012 - 2020 17. Global oral appliances demand, (Revenue), 2012 - 2020 18. Global oxygen devices demand, (Revenue), 2012 - 2020 19. Global other devices demand, (Revenue), 2012 - 2020 20. North America sleep apnea devices market by product (Revenue), 2012 - 2020 21. Europe sleep apnea devices market by product (Revenue), 2012 - 2020 22. Asia Pacific sleep apnea devices market by product (Revenue), 2012 - 2020 23. Japan sleep apnea devices market by product (Revenue), 2012 - 2020 24. RoW sleep apnea devices market by product (Revenue), 2012 - 2020
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.